Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosimetric Challenges of Small Lung Lesions in Low-Density Tissue Treated with Stereotactic Body Radiation Therapy.

Journal of clinical medicine·2026
Same author

Integrative Approaches in Non-Small Cell Lung Cancer Management: The Role of Radiotherapy.

Journal of clinical medicine·2024
Same author

Local Therapies for Hepatocellular Carcinoma and Role of MRI-Guided Adaptive Radiation Therapy.

Journal of clinical medicine·2023
Same author

Image-Based Deep Neural Network for Individualizing Radiotherapy Dose Is Transportable Across Health Systems.

JCO clinical cancer informatics·2023
Same author

Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma.

Science advances·2022
Same author

The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same journal

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same journal

Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.

JCO clinical cancer informatics·2026
Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K

Toward Automating the Summarization of Cancer Pathology Reports Using Large Language Models to Improve Clinical

Yirong Liu1, Jacob John1, Sagnik Sarkar1

  • 1Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL.

JCO Clinical Cancer Informatics
|April 8, 2026
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) generate concise pathology summaries, outperforming physician summaries in objective metrics and completeness. This demonstrates LLMs

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Related Experiment Videos

Last Updated: Jun 24, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Area of Science:

  • Oncology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Physicians face challenges integrating complex pathology data from multiple sources under time constraints.
  • Large language models (LLMs) offer potential for summarizing complex pathology findings.

Purpose of the Study:

  • To evaluate the performance of open-source LLMs in generating pathology summaries.
  • To compare LLM-generated summaries with physician-generated summaries for accuracy and completeness.

Main Methods:

  • Six LLMs (Llama 3.0, 3.1, 3.2, Mistral, Gemma, DeepSeek-R1) summarized original pathology reports from 94 thoracic clinic cases.
  • Summaries were objectively and subjectively evaluated against original reports and physician summaries.
  • Llama 3.1 underwent additional multi-evaluator subjective assessment.

Main Results:

  • LLM summaries significantly outperformed physician summaries in objective evaluation metrics (P < .0001).
  • DeepSeek, Mistral, Llama 3.1, and Llama 3.2 showed superior completeness in subjective evaluations (P < .0001).
  • LLM summaries maintained comparable correctness to physician summaries (P = 1.000).

Conclusions:

  • LLM-generated pathology summaries show superior objective performance and completeness compared to physician summaries.
  • LLMs show promise in improving clinical documentation and workflow efficiency in oncology.